9 days ago
PFE
AnalystsCarter GouldCarter Gould's Stock Forecasts
AnalystsCarter Gould
Analyst Ranking
Top 12%
#581 out of 4868 analysts
Average Return
+6.42%
Win Rate
52%64 out of 122
Risk vs Reward
Poor
Good
Carter Gould's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-08 - 2023-08-01 | Strong Buy |
Skillsoft CorpSKIL | +290.64% | $5.45 | $21.29 | 2024-04-15 - 2025-04-15 | Strong Buy |
Travere Therapeutics IncTVTX | +131.22% | $9.00 | $20.81 | 2024-08-01 - 2025-04-30 | Strong Buy |
Travere Therapeutics IncTVTX | +93.76% | $7.85 | $15.21 | 2023-09-21 - 2024-09-20 | Strong Buy |
Eli Lilly & CoLLY | +92.48% | $405.81 | $781.10 | 2023-04-30 - 2024-04-30 | Strong Buy |
Carter Gould Analyst Color
Get additional color on Carter Gould's coverage of popular stocks
9 days ago
MRK
9 days ago
LLY
9 days ago
GILD
4 months ago
NBIX
6 months ago
TVTX
6 months ago
LLY
7 months ago
ABBV
7 months ago
TVTX
9 months ago
REGN
9 months ago
NBIX
9 months ago
ABBV
10 months ago
LLY
10 months ago
PFE
10 months ago
REGN
a year ago
GERN
a year ago
ABBV
a year ago
LLY
a year ago
ABBV
a year ago
REGN
a year ago
NBIX
a year ago
LLY
a year ago
ABBV
a year ago
PFE
a year ago
PFE
Carter Gould's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bristol Myers Squibb CoBMY | 16 | Hold | $55.00 | +9.56% | Reiterates | 8 days ago |
Vertex Pharmaceuticals IncVRTX | 2 | Strong Buy | $535.00 | +5.00% | Assumes | 9 days ago |
Regeneron Pharmaceuticals IncREGN | 15 | Strong Buy | $695.00 | +16.07% | Assumes | 9 days ago |
Pfizer IncPFE | 14 | Hold | $24.00 | -1.68% | Initiates Coverage On | 9 days ago |
Merck & Co IncMRK | 11 | Hold | $85.00 | -0.23% | Initiates Coverage On | 9 days ago |
Eli Lilly & CoLLY | 12 | Strong Buy | $975.00 | +8.46% | Initiates Coverage On | 9 days ago |
Gilead Sciences IncGILD | 14 | Strong Buy | $125.00 | +17.33% | Assumes | 9 days ago |
Abbvie IncABBV | 15 | Strong Buy | $210.00 | +7.64% | Initiates Coverage On | 9 days ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $165.00 | +53.22% | Maintains | 4 months ago |
Travere Therapeutics IncTVTX | 6 | Strong Buy | $20.00 | -3.89% | Maintains | 6 months ago |
Biogen IncBIIB | 21 | Hold | $180.00 | +48.66% | Maintains | 6 months ago |
Amgen IncAMGN | 14 | Hold | $315.00 | +8.28% | Maintains | 7 months ago |
Nuvalent IncNUVL | 1 | Strong Buy | $100.00 | +30.29% | Initiates Coverage On | 8 months ago |
Vor Biopharma IncVOR | 3 | Strong Buy | $3.00 | +341.83% | Maintains | 9 months ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Strong Buy | $3.00 | +167.86% | Maintains | a year ago |
Geron CorpGERN | 1 | Strong Buy | $9.00 | +538.30% | Initiates Coverage On | a year ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $95.00 | +121.76% | Maintains | a year ago |
Skillsoft CorpSKIL | 5 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Arcellx IncACLX | 4 | Strong Buy | $73.00 | N/A | Maintains | a year ago |
Allakos IncALLK | 4 | Strong Sell | $1.00 | N/A | Maintains | a year ago |
Reata Pharmaceuticals IncRETA | 7 | Hold | $172.00 | N/A | Downgrades | 2 years ago |
Alector IncALEC | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Gossamer Bio IncGOSS | 5 | Hold | $1.50 | N/A | Maintains | 2 years ago |
Molecular Templates IncMTEM | 3 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Applied Therapeutics IncAPLT | 4 | Hold | $2.25 | N/A | Maintains | 3 years ago |
Paycom Software IncPAYC | 1 | Hold | $380.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Incyte CorpINCY | 3 | Hold | $82.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.